在SARS-CoV-2感染的口腔:一个病例报告
Lucie Rapp1,2,3,4, Thomas Gémar4,5, Marie-Hélène Lacoste-Ferré5
1Dental Faculty and Hospital of Toulouse - Toulouse Institute of Oral Medicine and Science, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
AME case reports
|May 7, 2024
概括
严重急性呼吸道综合征冠状病毒2 (SARS-CoV-2) 可能导致口腔,影响患者的生活质量. 这一案例凸显了牙科护理在管理COVID-19口腔表现方面的重要性.
科学领域:
- 口腔医学是指口腔医学.
- 传染性疾病 传染性疾病
- 牙科 牙科是指牙科的专业.
背景情况:
- 由SARS-CoV-2引起的COVID-19流行病导致了各种口腔健康问题.
- 报告的口腔表现包括异口症,状病变,和味觉障碍.
研究的目的:
- 描述COVID-19感染后口腔的临床病例.
- 强调COVID-19患者口腔检查的重要性.
主要方法:
- 一个95岁的男性患者感染COVID-19的病例报告.
- 临床检查显示,舌头和嘴唇上有痛苦的口腔.
- 治疗包括止痛药,专门的口水,麻醉凝和修改后的饮食.
主要成果:
- 患者经历了明显的口腔灼热和.
- 实施了一种多学科的症状管理方法.
- 在13天内,口腔症状逐渐改善.
结论:
- 口腔是COVID-19的一个显著表现,影响患者的福祉.
- 这些病变会导致疼痛,压力和营养困难,特别是在老年患者中.
- 牙医在识别和管理与SARS-CoV-2感染相关的口腔症状方面发挥着至关重要的作用.
相关概念视频
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Diabetic Foot Ulcer
Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...
Peptic Ulcer Disease II: Pathophysiology
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease III: Clinical Manifestations and Complications
Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant use.Gastric UlcersGastric ulcers share...


